Retigabine

CAS No. 150812-12-7

Retigabine ( D 23129; GKE-841; GW 582892X; WAY-143841 )

Catalog No. M12105 CAS No. 150812-12-7

Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Retigabine
  • Note
    Research use only, not for human use.
  • Brief Description
    Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
  • Description
    Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
  • Synonyms
    D 23129; GKE-841; GW 582892X; WAY-143841
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    KCNQ2/Q3 channels; KCNQ3/5; KCQN4
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    150812-12-7
  • Formula Weight
    303.33
  • Molecular Formula
    C16H18FN3O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.M.J. Brodie, et al. Neurology November 16, 2010 vol. 75 no. 20 1817-1824 .
molnova catalog
related products
  • Dronedarone hydrochl...

    A multichannel blocker agent that has antiarrhythmic activity.

  • BMS-813160

    BMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.

  • MK-0448

    MK-0448 is a potent, specific I(Kur) current/Kv1.5 channel inhibitor with IC50 of 8.6 nM, potently inhibits IKur in human atrial myocytes with IC50 of 10.8 nM.